The genus Mycobacterium consists of at least more than 150 recognized species (LPSN database last accessed on 13th September 2017) [http://www.bacterio.net/index.html]. Pathogenicity ranges from environmental saprophytes to the pathogenic and health hazard M. tuberculosis. Tuberculosis is one of the leading causes of morbidity and mortality with 1.8million deaths and 10.4million new cases every year worldwide and continues to be a public health problem globally.
The genus Mycobacterium consists of at least more than 150 recognized species (LPSN database last accessed on 13th September 2017) [http://www.bacterio.net/index.html]. Pathogenicity ranges from environmental saprophytes to the pathogenic and health hazard M. tuberculosis. Tuberculosis is one of the leading causes of morbidity and mortality with 1.8million deaths and 10.4million new cases every year worldwide and continues to be a public health problem globally. 1 A number of the environmental mycobacterium species, collectively known as non-tuberculosis mycobacteria (NTM), are responsible for many opportunistic infections that are increasingly common among immune-compromised individuals. Speciation is important to ascertain the clinical significance of the mycobacteria isolated. Also, differentiation of the Mycobacterium Tuberculosis Complex (MTC) and NTM has become important due to the rise of infections and antimicrobial resistance in this genus.
Conventional methods of identification include growth characteristics, temperature and rate of growth, colony pigmentations, biochemical reactivity etc. These are laborious, difficult to perform and require additional time after the culture flags positive hence most laboratories find these difficult to adopt in routine settings. Nowadays, positive cultures are identified as MTC based on smear morphology and methods like immunochromatography (MPT64 antigen) wherein NTM is a diagnosis of exclusion. Post-culturing, reliable molecular line probe assay like Geno Type CM/AS (Hain test) enables rapid (within 24hours) and reliable speciation of 32 clinically relevant mycobacteria and differentiates MTC from NTMs. Though reliable and highly sensitive, the test is laborious, requires skilled technologists, is expensive and therefore is mostly available in reference laboratories. Also, the assay is able to detect only a limited number of specified targets against which the probes are directed.
With the rise of opportunistic pathogens and with several new species being named annually, the need to have a rapid and reproducible identification method for a wider range of Mycobacterium species is evident. Recent developments in mass spectrometry (MS) have made it possible to use matrix-assisted laser desorption ionization-time-offlight MS (MALDI-TOF MS) or MALDI to aid in the identification of microorganisms. In recent years, several reports have shown the feasibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for the identification of microorganisms in routine clinical microbiology laboratories. 2 Qualified spectra for the identification of various bacteria have been determined, but the methods for identifying mycobacteria species are new. [3] [4] [5] Most studies utilizing MALDI-TOF MS for NTM identification have used culture collections rather than fresh positive cultures from clinical specimens. A PCR-sequencing method based on hsp65, the gene encoding the 65-kilodalton heat shock protein, has also been used extensively for differentiating M. tuberculosis from other NTM members.
The current study was aimed to demonstrate the utility of MALDI-TOF MS for the identification of clinical mycobacterial isolates in a large microbiology laboratory. Further the results of MALDI-TOF MS were validated using gold standard hsp65 gene sequencing. To the best of our knowledge, this is the first comprehensive study from India characterizing a large number of various Mycobacterium species by MALDI-TOF MS and sequencing, on isolates grown in liquid culture.
A total of 56 archived isolates and 4 CAP proficiency isolates were analyzed. For MALDI TOF MS analysis mycobacteria positive liquid culture (3ml) was collected in a 5-ml vortex bottle. Vortex bottle was centrifuged at 3000g for 10min. After discarding supernatant, pellet was re-suspended in 500μL of 70% ethanol. The suspension was transferred to a vial containing 0.5mm glass beads. "Bead beat" treatment was given for 5min and incubated at room temperature for 10min. After vortexing and transferring to fresh micro tube, it was centrifuged at 14000g for 2min. The pellet was re-suspended in 10μL of 70% formic acid followed by addition of 10μL of 100% acetonitrile and spinning at 14000g for 2 min. OneμL of the supernatant was spotted on a MS target slide and subjected to air-dry. The spot was overlaid with 1μL of CHCA (α-cyano-4-hydroxycinnamic acid) matrix solution followed by air-dry. The slide was processed using the VITEK-MS instrument. Mass spectra were analyzed using automatic database within MYLA software (Biomerieux, France). IVDv3.0 database of VITEK-MS was used in our study.
For
A total of 60 isolates, representing 17 species belonging to 8 groups of Mycobacteria were used to assess the performance and clinical validity of the MALDI-TOF MS system. These isolates were grown in mycobacterium growth indicator tubes (MGIT), the media commonly used for mycobacteria isolation in corresponding laboratory. In order to validate our results, the same clinical isolates were subjected to hsp65 gene sequencing separately. pathogens that cause a wide spectrum of clinically significant symptoms. M. porcinum, a rapidly-growing pathogenic species of human has been reported to cause post-traumatic or post-surgical wound infections, osteomyelitis, and catheter-related infections. 7 M. conceptionense has been reported to cause infection after breast implant surgery as well as a subcutaneous abscess in an immunecompetent patient. 8 Reports also reveal that they are resistant to most first-line anti-tuberculous agents.
MALDI-TOF
9 It is therefore important for practitioners to be aware of these rapidly-growing opportunistic and pathogenic microorganisms as possible etiological agents. Although the number of isolates in our study was not large enough (N=60) and the number of species was lower (N=17), our results show that identification using MALDI-TOF is reliable in majority of clinically-relevant species of NTM (M. avium, M. intracellulare, M. abscessus, M. chelonae, M. fortuitum, M. kansasii, M. scrofulaceum). Several studies have documented the effect of culture time on the accuracy of identifying mycobacterial species. 10, 11 Few authors have found dissimilarities in identification depending upon the culture media used, the culture growth time, the extraction protocol applied to the mycobacteria, or the library (i.e. Bruker Biotyper and Vitek MS databases) used. [10] [11] [12] Our results were obtained from clinical isolates, where most of them were assayed within 2-5 days of growth in MGIT liquid medium. 13 Our study demonstrated that besides low cost and accuracy, MALDI-TOF MS procedure involves little handling and few working hours, which reduces the potential risk of infections caused by mycobacteria in the laboratory. MALDI-TOF MS could be regarded as an alternate diagnostic tool for identification and differentiation of clinical isolates of Mycobacterium. Sequence-based identification remains a complimentary approach for evaluation of unidentified isolates. In order to have comprehensive clinical diagnosis, Sanger sequencing and /or Next Generation Sequencing technology can be utilized by clinical laboratories.
